In addition, OS rates were significantly poorer in patients with decreased ApoA-I levels than in patients with high ApoA-I levels, and this was independent of other variables predicting the prognosis of ESCC patients. This evidence concerns the gene APOA1 and esophageal squamous cell carcinoma.